Infective endocarditis resident survival guide
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farman Khan, MD, MRCP [2]; Mohamed Moubarak, M.D. [3]; Rim Halaby, M.D. [4]
Infective endocarditis Resident Survival Guide Microchapters |
---|
Overview |
Causes |
FIRE |
Diagnosis |
Treatment |
Prophylaxis |
Do's |
Don'ts |
Overview
Infective endocarditis is the infection of the endothelium of the heart including but not limited to the valves. While acute bacterial endocarditis is caused by an infection with a virulent organism such as staphylococcus aureus, group A or other beta-hemolytic streptococci, subacute bacterial endocarditis is an indolent infection with less virulent organisms like streptococcus viridans. Patients with unexplained fever for more than 48 hours and who are at high risk for infective endocarditis and patients among whom valve regurgitation is newly diagnosed should undergo a diagnostic workup to rule out endocarditis. The diagnosis of endocarditis depends on a thorough history and physical exam as well as on the results of blood cultures and transthoracic echocardiogram. The modified Duke criteria is used to establish the diagnosis of endocarditis. Endocarditis is initially treated with empiric antibiotic therapy until the causative agent is identified.[1][2]
Causes
Life Threatening Causes
Acute endocarditis is a life-threatening condition and must be treated as such irrespective of the underlying cause.
Common Causes
FIRE:Focused Initial Rapid Evaluation
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.[1][3]
Boxes in salmon color signify that an urgent management is needed.
Abbreviations: TEE: Transesophageal echocardiography; TTE: Transthoracic echocardiography
Identify cardinal signs and symptoms that increase the pretest probability of endocarditis ❑ Persistent fever
| |||||||||||||||||||||||||||||||||||||||||||||||
❑ Order blood cultures (at least 2 sets) ❑ Order TTE, or ❑ Order a TEE if one or more of the following is present
❑ Evaluate the modified Duke criteria | |||||||||||||||||||||||||||||||||||||||||||||||
Identify findings suggestive of complications of endocarditis that require urgent intervention | |||||||||||||||||||||||||||||||||||||||||||||||
Cardiac complications | Extra cardiac complications | No complications | |||||||||||||||||||||||||||||||||||||||||||||
❑ Severe valvular insufficiency ❑ Valvular abscess ❑ Valvular dehiscence ❑ Valvular rupture ❑ Valvular fistula ❑ Periannular extension of the infection | Focal neurological deficits ❑ Facial droop ❑ Unilateral hemiparesis ❑ Aphasia ❑ Neglect ❑ Hemianopsia ❑ Headache ❑ Altered mental status | ❑ Tender pulsatile mass ❑ Hematemesis, hemobilia, jaundice (suggestive of involvement of the hepatic artery) ❑ Hypertension Hematuria (suggestive of involvement of the renal artery) ❑ Massive bloody diarrhea (suggestive of involvement of a bowel artery) | |||||||||||||||||||||||||||||||||||||||||||||
❑ Order CT scan or MRI | |||||||||||||||||||||||||||||||||||||||||||||||
Embolism to the brain | |||||||||||||||||||||||||||||||||||||||||||||||
❑ Consider valve replacement surgery | ❑ Evaluate medical vs surgical intervention | ❑ Consider surgical ligation of the involved artery | |||||||||||||||||||||||||||||||||||||||||||||
Complete Diagnostic Approach
A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.[1][2]
Abbreviations: TEE: Transesophageal echocardiography; TTE: Transthoracic echocardiography
Characterize the symptoms: ❑ Onset of the symptoms
❑ Fever | |||||||||||||||||||||||
Identify existing risk factors for endocarditis: ❑ History of rheumatic heart disease
❑ Previous infective endocarditis | |||||||||||||||||||||||
Examine the patient: Vitals
Skin
Dental examination Eyes ❑ Conjunctival hemorrhage Cardiovascular examination ❑ Heart murmur: New or change in the character of a previous murmur
Respiratory examination ❑ Rales (suggestive of heart failure) Abdominal examination ❑ Reduced bowel sounds (suggestive of mesenteric embolization or ileus)
Extremities ❑ Janeway lesions (painless hemorrhagic cutaneous lesions on the palms and soles) Neurological examination ❑ Full neurological exam
| |||||||||||||||||||||||
Order tests: ❑ Blood culture (at least two sets)
| |||||||||||||||||||||||
Evaluate the Modified Duke Criteria for infective endocarditis:[4]
| |||||||||||||||||||||||
Consider alternative diagnoses: ❑ Culture negative endocarditis
❑ Cellulitis (skin inflammatory skin) | |||||||||||||||||||||||
Treatment
Shown below is an algorithm depicting the management of infective endocarditis.[1][2]
Abbreviations: TEE: Transesophageal echocardiography; TTE: Transthoracic echocardiography
Once the diagnosis of infective endocarditis is confirmed, initiate the treatment:
❑ Begin antibiotic treatment
❑ Remove the pacemaker of the defibrillator system if one of the following is present
❑ Manage the patient with a multidisciplinary team
| |||||||||||||||||||
Does the patient have any of the following conditions that require an early valve replacement surgery during hospitalization? ❑ Heart failure due to the valve dysfunction (Class I, level of evidence B) | |||||||||||||||||||
Yes | No | ||||||||||||||||||
❑ Schedule for early surgery | |||||||||||||||||||
Follow up the patient: ❑ Repeat TTE before discharge
| |||||||||||||||||||
Reevaluate the patient with TTE and/or TEE if one of the following is present: ❑ Change in clinical signs and symptoms
❑ High risk of complications
| |||||||||||||||||||
Antibiotic Regimens
A complete list of pathogen specific antibiotics regimens with appropriate dosages and duration of treatment is available here.
Modified Duke Criteria
Shown below is a table summarizing the major and minor Modified Duke Criteria.[4]
|
Prophylaxis
Shown below is an algorithm depicting the general prophylactic approaches of infective endocarditis.[5][1]
Identify high risk patients: (Class IIa, Level of evidence B)
❑ Prosthetic valves patients
| |||||||||
Identify high risk procedures:
❑ Respiratory tract procedures involving incision of the respiratory tract mucosa ❑ Gastrointestinal (GI) and genitourinary (GU) procedures only if GI or GU tract infection is present | |||||||||
❑ Administer prophylaxis
| |||||||||
Antibiotic Prophylaxis
Shown below is a table depicting the prophylaxis antibiotic regimes for infective endocarditis.[1]
|
Do's
- Elicit a full medical history to identify the minor Duke criteria for the diagnosis.
- Consider alternative diagnoses for bacteremia and fever by searching for focus of infections.
- Initiate antibiotic therapy after withdrawing blood for culture (Class I, level of evidence B).[1]
- If the blood cultures are negative in a patient suspected to have infective endocarditis, suspect HACEK infection and ask the laboratory to retain the blood cultures for more than two weeks.[2]
- If HACEK bacteremia is detected without any focus of infection, suspect the presence of infective endocarditis even in the absence of the typical signs and symptoms.[2]
- Do a transesophageal echocardiography intraoperatively among patients scheduled for valve surgery for infective endocarditis (Class I, level of evidence B).[1]
- Consider ordering a cardiac CT scan when echocardiography does not provide clear details about the cardiac anatomy in the context of suspected paravalvular infections (Class IIa, level of evidence B).[1]
- Suspect intraventricular septal abscess as a complication of endocarditis when the ECG is significant for a gradual increase in the PR interval or a new left bundle branch block.[3]
Don'ts
- Don't administer prophylaxis for infective endocarditis in patients with valvular heart disease who are at risk infective endocarditis for procedures such as transesophageal echocardiography, cystoscopy, esophagogastroduodenoscopy or colonoscopy without any evidence of active infection (Class III; level of evidence B).[1]
- Do not administer infective endocarditis prophylaxis for the following dental procedures:
- Anesthetic injections in noninfected tissue
- Dental radiographs
- Shedding of deciduous teeth
- Placement of orthodontic brackets
- Placement or removal of prosthodontic or orthodontic appliances
- Adjustment of orthodontic appliances
- Bleeding following trauma to the oral mucosa or lips[6]
- Do not administer prophylaxis for infective endocarditis for procedures involving the respiratory tract unless they involve incision of the respiratory tract mucosa.[6]
- Do not administer cephalosporins in subjects with a previous history of anaphylaxis, angioedema, or urticaria following penicillin or ampicillin use.
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary". Retrieved 4 March 2014.
- ↑ 2.0 2.1 2.2 2.3 2.4 Baddour, LM.; Wilson, WR.; Bayer, AS.; Fowler, VG.; Bolger, AF.; Levison, ME.; Ferrieri, P.; Gerber, MA.; Tani, LY. (2005). "Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America". Circulation. 111 (23): e394–434. doi:10.1161/CIRCULATIONAHA.105.165564. PMID 15956145. Unknown parameter
|month=
ignored (help) - ↑ 3.0 3.1 Weinstein L (1986). "Life-threatening complications of infective endocarditis and their management". Arch Intern Med. 146 (5): 953–7. PMID 3516105.
- ↑ 4.0 4.1 Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T; et al. (2000). "Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis". Clin Infect Dis. 30 (4): 633–8. doi:10.1086/313753. PMID 10770721.
- ↑ Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M; et al. (2007). "Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group". Circulation. 116 (15): 1736–54. doi:10.1161/CIRCULATIONAHA.106.183095. PMID 17446442.
- ↑ 6.0 6.1 Bonow RO, Carabello BA, Chatterjee K; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172. Unknown parameter
|month=
ignored (help)